SEC Form 4 · accession 0001225208-18-006511

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Daniel J. Brennan

Officer — EVP and CFO

Period of report

Mar 19, 2018

Accepted (ET)

Mar 20, 2018 · 6:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 19, 2018	M	20,461	$7.41	A	299,644	D
Common Stock	Mar 19, 2018	M	13,661	$13.08	A	313,305	D
Common Stock	Mar 19, 2018	M	12,422	$7.16	A	325,727	D
Common Stock	Mar 19, 2018	M	7,572	$7.39	A	333,299	D
Common Stock	Mar 19, 2018	M	6,093	$6.28	A	339,392	D
Common Stock^F2	Mar 19, 2018	S	60,209	$27.8698	D	279,183	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$7.41	Mar 19, 2018	M	20,461	D	—	Feb 16, 2020	Common Stock	20,461	40,925	D
Stock Option (Right to Buy)^F4	$13.08	Mar 19, 2018	M	13,661	D	—	Feb 24, 2024	Common Stock	13,661	40,984	D
Stock Option (Right to Buy)^F5	$6.28	Mar 19, 2018	M	6,093	D	—	Feb 27, 2022	Common Stock	6,093	12,187	D
Stock Option (Right to Buy)^F6	$7.16	Mar 19, 2018	M	12,422	D	—	Feb 28, 2021	Common Stock	12,422	24,846	D
Stock Option (Right to Buy)^F7	$7.39	Mar 19, 2018	M	7,572	D	—	Feb 28, 2023	Common Stock	7,572	15,144	D

Explanation of responses

F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $27.68 to $28.02, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
F4Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
F5Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F6Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
F7Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.